Strategic Imperative – The Enterprise Data Model

View this webinar where our experts discussed the new era of analytics with the Microsoft Azure Synapse Analytics platform. It is a limitless analytics service with unmatched time to insight that bring together data integration, enterprise data warehousing and big data analytics – all into a single service.

Currently, the Cleveland Clinic Biorepository is an assembly of several biobanks together with the Lerner Research Institute. Excel spreadsheets track almost everything – and there are no universal LIS, SOPs, universal, centralized freezer monitoring, or means to electronically track patient tissue. The Cleveland Clinic is embarking on an enterprise-wide initiative to accelerate its biobanking capacity, leveraging its clinical volume and disease expertise. As part of this initiative, the Cleveland Clinic is partnering with Brooks Life Sciences to build a state of the art, 21,000 square-foot structure biobanking facility, set to open in the summer of 2019.

Business users have a tremendous appetite for data. The “single version of the truth” was a rallying cry to deliver business data in data warehouses for years. Users were able to digest and analyze large volumes of corporate data. They reviewed trends, identified anomalies, and supported decision-making because they had the detailed data to support action. As the business/data environment matured, the need for more diverse detail and increased delivery speed only grew. The data lake became a successful mechanism for delivering data from diverse systems in a timely manner.

As organizations move into the cloud, the choices for handling high-scale data for analytical use are flourishing and evolving. How do we address BI/analytics, data science, security/application monitoring, and log data management workloads? Do we really need potentially overlapping warehouse, data lake, and security and observability capabilities on top of object storage, or can an evolved data lake or emerging “lakehouse” platform do it all? Join Doug Henschen, VP and principal analyst at Constellation Research and Thomas Hazel, Chief Technology and Science Officer at ChaosSearch for a broad-ranging discussion on the challenges and strategy considerations that go into choosing the right platform.